概括
这项研究表明,六甲基胺和西斯胺化疗对晚期卵巢癌有效,可提供显著的疾病回归和延长生存时间. 门诊治疗方案尽量减少脏损伤,使其成为可行的治疗选择.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学 是一个学科.
背景情况:
- 晚期卵巢癌经常进展,尽管有化剂治疗.
- 对于治疗耐药性疾病的患者,需要新的化疗方案.
研究的目的:
- 评估前期治疗失败的晚期卵巢癌患者的六甲基胺和西斯普拉丁联合化疗的疗效和安全性.
- 为了评估添加多克索鲁比辛化到该疗程的影响.
主要方法:
- 一组27名患有晚期卵巢癌和基化剂疾病进展的患者接受了组合化疗.
- 治疗涉及六甲基胺和西斯,有或没有多克索鲁比辛化.
- 监测患者的反应,生存和不良事件,包括毒性和骨髓抑制.
主要成果:
- 客观响应率为67% (回归率高于50%),预计响应的中位持续时间为7个月.
- 预计的中位生存时间是从研究开始后的9个月和诊断后的33个月.
- 这种疗法在门诊治疗中耐受性很好,补水和尿液可以防止白金诱导的管损伤. 严重的骨髓抑制发生在40%的患者中,没有与治疗相关的死亡.
结论:
- 甲基胺和西斯普拉丁组合化疗在晚期卵巢癌中表现出显著的活性.
- 该疗法可用于门诊治疗,有可控毒性.
- 这些药物应考虑在III和IV期卵巢癌的初始治疗中使用.
相关概念视频
Alkynes to Aldehydes and Ketones: Hydroboration-Oxidation
Introduction
One of the convenient methods for the preparation of aldehydes and ketones is via hydration of alkynes. Hydroboration-oxidation of alkynes is an indirect hydration reaction in which an alkyne is treated with borane followed by oxidation with alkaline peroxide to form an enol that rapidly converts into an aldehyde or a ketone. Terminal alkynes form aldehydes, whereas internal alkynes give ketones as the final product.
One of the convenient methods for the preparation of aldehydes and ketones is via hydration of alkynes. Hydroboration-oxidation of alkynes is an indirect hydration reaction in which an alkyne is treated with borane followed by oxidation with alkaline peroxide to form an enol that rapidly converts into an aldehyde or a ketone. Terminal alkynes form aldehydes, whereas internal alkynes give ketones as the final product.
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


